1. Home
  2. NXPL vs GDTC Comparison

NXPL vs GDTC Comparison

Compare NXPL & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NextPlat Corp

NXPL

NextPlat Corp

HOLD

Current Price

$0.55

Market Cap

15.6M

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.32

Market Cap

16.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXPL
GDTC
Founded
1997
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.6M
16.9M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
NXPL
GDTC
Price
$0.55
$1.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
188.1K
41.7K
Earning Date
11-13-2025
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$57,151,000.00
$573,193.00
Revenue This Year
N/A
$5.37
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
63.03
52 Week Low
$0.43
$1.29
52 Week High
$2.30
$4.05

Technical Indicators

Market Signals
Indicator
NXPL
GDTC
Relative Strength Index (RSI) 39.44 30.92
Support Level $0.53 $1.49
Resistance Level $0.59 $1.63
Average True Range (ATR) 0.06 0.10
MACD -0.00 -0.01
Stochastic Oscillator 11.42 7.69

Price Performance

Historical Comparison
NXPL
GDTC

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: